Skip Nav Destination
Abstract PD2-12: Palbociclib in combination with fulvestrant or tamoxifen as treatment for hormone receptor positive (HR+) metastatic breast cancer (MBC) with prior chemotherapy for advanced disease (TBCRC 035) A phase II study with pharmacodynamics markers
Cancer Res (2019) 79 (4_Supplement): PD2-12.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Johannes Ettl
- Seock-Ah Im
- Jungsil Ro
- Norikazu Masuda
- Marco Colleoni
- Patrick Schnell
- Eustratios Bananis
- Dongrui R. Lu
- Massimo Cristofanilli
- Hope S. Rugo
- Richard S. Finn
Breast Cancer Research (2020) 22 (1)